Xeris Biopharma Holdings (XERS) Asset Utilization Ratio (2021 - 2026)

Xeris Biopharma Holdings' Asset Utilization Ratio history runs 6 years deep, the most recent figure standing at 0.81 for Q1 2026.

• Quarterly Asset Utilization Ratio rose 16.48% year-over-year to 0.81 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.81 (up 16.48% YoY) and the FY2025 annual result came in at 0.83, up 31.32% from the prior year.
• Asset Utilization Ratio was 0.81 for Q1 2026 at Xeris Biopharma Holdings, up from 0.77 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 0.81 in Q1 2026 and bottomed at 0.2 in Q1 2022.
• A 5-year average of 0.52 and a median of 0.52 in 2024 frame the typical range for Asset Utilization Ratio.
• Annual changes were most pronounced in 2023 — Asset Utilization Ratio surged 84.37% — and 2026, when it climbed 16.48%.
• Xeris Biopharma Holdings' Asset Utilization Ratio stood at 0.34 in 2022, then jumped by 48.03% to 0.5 in 2023, then rose by 25.08% to 0.63 in 2024, then climbed by 22.83% to 0.77 in 2025, then advanced by 4.85% to 0.81 in 2026.
• Business Quant data shows XERS's Asset Utilization Ratio at 0.81 in Q1 2026, 0.77 in Q4 2025, and 0.76 in Q3 2025.